This prospective, non-randomized, multi-center study is intended to evaluate the Zilver® Vena™ stent in the treatment of symptomatic iliofemoral venous outflow obstruction.
Study Type
OBSERVATIONAL
Enrollment
35
Stenting iliofemoral venous outflow obstruction
Klinikum Arnsberg GmbH
Arnsberg, Germany
Galway University Hospitals
Galway, Ireland
Hospital Madrid Monteprincipe
Madrid, Spain
Kantonsspital Winterthur
Winterthur, Switzerland
Guy's and St Thomas' Hospital
Major Adverse Events
Time frame: 1 month
Patency
Assessed via ultrasound
Time frame: 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
London, United Kingdom